Exactus Top Insiders
Exactus employs about 4 people. The company is managed by 13 executives with a total tenure of roughly 74 years, averaging almost 5.0 years of service per executive, having 0.31 employees per reported executive. Assessment of Exactus' management performance can provide insight into the firm performance.
| Jonathan Gilbert Chairman Executive Chairman of the Board |
| Philip Young Chairman Chairman of the Board and Presidentident, CEO |
Exactus |
Exactus Management Team Effectiveness
The company has return on total asset (ROA) of (137.67) % which means that it has lost $137.67 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (481.75) %, meaning that it created substantial loss on money invested by shareholders. Exactus' management efficiency ratios could be used to measure how well Exactus manages its routine affairs as well as how well it operates its assets and liabilities.Exactus Workforce Comparison
Exactus is one of the top stocks in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 184,227. Exactus adds roughly 4.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Exactus Notable Stakeholders
An Exactus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Exactus often face trade-offs trying to please all of them. Exactus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Exactus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jonathan Gilbert | Executive Chairman of the Board | Profile | |
| Philip Young | Chairman of the Board and Presidentident, CEO | Profile | |
| Timothy Ryan | Executive Vice President Director | Profile | |
| Emiliano Aloi | President | Profile | |
| Kelley Wendt | CFO, Treasurer | Profile | |
| Kenneth Puzder | Independent Director | Profile | |
| Steven Schwartz | Independent Director | Profile | |
| John Price | Independent Director | Profile | |
| Krassen Dimitrov | Director | Profile | |
| Vladislav Yampolsky | Independent Director | Profile | |
| Jeffrey Thompson | Independent Director | Profile | |
| Bobby Yampolsky | Director | Profile | |
| Kevin Esval | Independent Director | Profile |
Exactus Workforce Analysis
Traditionally, organizations such as Exactus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Exactus within its industry.Exactus Manpower Efficiency
Return on Exactus Manpower
| Revenue Per Employee | 310K | |
| Revenue Per Executive | 95.4K | |
| Net Loss Per Employee | 3.4M | |
| Net Loss Per Executive | 1.1M | |
| Working Capital Per Employee | 208.2K | |
| Working Capital Per Executive | 64.1K |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Exactus information on this page should be used as a complementary analysis to other Exactus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Exactus OTC Stock
If you are still planning to invest in Exactus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exactus' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |